[EN] C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USE<br/>[FR] STÉROÏDES NEUROACTIFS SUBSTITUÉS EN C7, C12 ET C16 ET MÉTHODES D'UTILISATION ASSOCIÉES
申请人:SAGE THERAPEUTICS INC
公开号:WO2018013615A1
公开(公告)日:2018-01-18
Described herein are neuroactive steroids of Formula (I), Formula (V), or Formula (IX) or a pharmaceutically acceptable salt thereof; wherein each instance of R2, R3, R4, R5, R6, R7, R11a, R11b,R12, R16, R17, R19, and ----- are as defined herein. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. Also provided are pharmaceutical compositions comprising a compound described herein and methods of use and treatment, e.g., such as for inducing sedation and/or anesthesia.
本文描述了化学式(I)、化学式(V)或化学式(IX)的神经活性类固醇或其药用盐;其中R2、R3、R4、R5、R6、R7、R11a、R11b、R12、R16、R17、R19和-----的每个实例如本文所定义。在某些实施例中,这些化合物被设想为GABA调节剂。还提供了包含本文描述的化合物的药物组合物以及使用和治疗方法,例如用于诱导镇静和/或麻醉。